Biodexa Pharmaceuticals PLC, an acquisition-focused clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, today ...

Oatly is changing the ratio of its American Depositary Receipts (ADRs) to ordinary shares, which could enhance the trading price per ADR by making each ADR represent a larger proportion of ordinary ...

Biodexa Pharmaceuticals PLC has announced a change in its American Depositary Receipts (ADR) ratio, effective July 31, 2025. The new ratio will be one ADR representing 100,000 ordinary shares, up from ...

HANGZHOU, China, Sept. 11, 2024 /PRNewswire/ -- Yunji Inc. (YJ) ("Yunji" or the "Company"), a leading membership-based social e-commerce platform, today announced that it plans to change the ratio of ...